The Duke Cancer Institute's Biospecimen Repository and Processing Core/Shared Resource (BRPC) is the result of substantially increased institutional support for biobanking at Duke since the last CCSG renewal. The BRPC utilizes the strong infrastructure of the previous CCSG-supported biobanking Shared Resource, the Tissue and Blood Procurement Core, and incorporated its existing collection. However, the BRPC has significant advantages to DCI members because it stems from a concerted institutional and ground-up effort to reinvent and strengthen the resource to better meet biobanking needs across the institution. The BRPC's priority is to maximize tissue available for research while ensuring that sufficient, intact tissue is available for clinical pathologic assessment and reporting. It achieves this by integration with the Department of Pathology, and it functions under the favored honest-broker model of biobanking. BRPC obtains consent and collects tissue for both true excess tissue surgical events as well as additional tissue biopsy events (paired needle core breast biopsies, for example). Governance of biospecimen use is provided separately by the 10 disease-site groups of the DCI (distinct from but overlapping the nine CCSG-identified Research Programs) for relevant biospecimens. Since inception of the facility in 2012, BRPC services have been utilized by 49 Duke faculty, 38 of whom are DCI members. The DCI users represent eight of the nine DCI CCSG-recognized Research Programs. The BRPC operating budget is supported by the DCI (71%) and the Duke School of Medicine (29%) to support the initial growth and development of the BRPC. Year one of operations was completely subsidized (for 600 unique patient biobanking consenting and collection events) in an effort to increase investigator and disease- site working group awareness of the shared resource. In year two and beyond, gradual charge backs have been implemented and satisfied investigators are building the BRPC into their grant and contract applications. The BRPC's immediate objectives are to (1) engage additional user groups from the DCI; (2) prepare for the transition to a new informatics system expected in mid-2014. Our long-term objectives are to formalize a process for true overnight banking across multiple interested parties and to provide DCI members access to Duke's clinical archives of paraffin-embedded biospecimens, in accordance with clinical requirements.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-43
Application #
9198505
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-01-01
Budget End
2017-12-31
Support Year
43
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Duan, Bensong; Hu, Jiangfeng; Liu, Hongliang et al. (2018) Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Int J Cancer 142:1322-1331
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784

Showing the most recent 10 out of 513 publications